Bearish
DaVita (US23918K1088) has seen a strong rally over the past year, but its stock is now facing increased volatility due to fresh regulatory headlines a...
Bullish
Health systems like Centerwell, Rush, and DaVita are investing in chronic disease technology, showing promise for AI in this sector. This comes as Nou...
Bullish
DaVita Inc. (DVA) recently reported strong Q1 2026 results, with increased revenue and net income, alongside significant share repurchases totaling bi...
Bullish
DaVita Inc. has seen a significant stock rally in 2026, gaining nearly 70% year-to-date despite a recent dip in healthcare stocks. The company, a majo...
DaVita Inc.'s CFO & Treasurer, Joel Ackerman, recently sold 34% of his holdings in the company, netting approximately US$9.9 million. While a signific...
Bullish
Following strong Q1 results, DaVita's shares are trading near 52-week highs, with a 6% revenue growth reported for fiscal year 2026. TD Cowen has incr...
Bullish
DaVita (US23918K1088) exceeded expectations in Q1 with an adjusted EPS of $2.87 and recorded $140 million in free cash flow. The company subsequently ...
Neutral
DaVita (DVA) stock has experienced a 6-day winning streak, increasing 31% and adding $3.2 billion to its market cap. Despite this surge, Trefis evalua...
Bullish
DaVita Inc. (DVA) saw its shares jump after beating Q1 2026 earnings estimates, raising its full-year guidance, and reporting strong cash flow, signal...
DaVita Inc. reported stronger-than-expected Q1 2026 results with increased net income and EPS on modest revenue growth, suggesting improved operationa...
DaVita (DVA) is set to report its Q1 earnings this Tuesday after market hours. The market anticipates a 3.8% year-on-year revenue growth, a slight slo...